Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Paulus, H. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Paulus, H. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 British Society for Rheumatology

Clinical Trial Design for Evaluating Combination Therapies

H. E. Paulus

University of California, Los Angeles California, USA


  Abstract

Because the differences in efficacy between a disease-modifying antirheumatic drug (DMARD) combination and its constituent drugs are likely to be smaller than those between placebo and the single DMARDs, it has been difficult to prove that any combination of DMARDs has either additive or synergistic benefit. The discriminatory power of the study design can be enhanced by careful attention to the details of patient selection, study design and duration, and choices of primary outcome measures and analytical methods. Use of the American College of Rheumatology (ACR) ‘core set’ of outcome measures and the proposed ACR ‘definition of improvement’ for rheumatoid arthritis (RA) clinical trials, with intent-to-treat analysis, in a balanced, prospective, double-blind randomized clinical trial of 1–2 yr duration will optimize the chances of discriminating between the clinical benefit of the combination and its components if a real difference is present.

KEY WORDS: Combination therapy, Rheumatoid arthritis, Disease-modifying antirheumatic drug


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.